Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8 + T cell-mediated antitumour immunity and improves anti-PD-1 efficacy.
Ning CaiKun ChengYue MaSha LiuRan TaoYani LiDanfeng LiBin GuoWenlong JiaHuifang LiangJianping ZhaoLimin XiaZe-Yang DingJin-Hong ChenWanguang ZhangPublished in: Gut (2023)
HCC.